4
Changes in Ownership
aTYR PHARMA INC Filed Acc 0001209191-18-008625
Options or other derivatives
- Chief Scientific Officer acquired 150,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| King David John Chief Scientific Officer | 2018-02-06 | Grant or award · Employee Stock Option (right to buy) | +150,000 | 150,000 | D | ||
Loading xslF345X03/doc4.xml…